Watchdog Group Wants FDA Leaders Removed for Okaying Aducanumab

Backlash towards the FDA’s motion grows, whereas advocates who supported approval of the Alzheimer’s drug now are upset over its $56,000 price. Medscape Medical News
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here